ABUS
Arbutus Biopharma · USD
Deep AI analysis (big model)
No deep analysis yet. Portfolio holdings are analysed automatically; for any other stock, click “Request deep AI analysis” above.
About Arbutus Biopharma
Arbutus Biopharma is a biopharmaceutical company focused on developing and commercializing treatments for cancer and other serious diseases, operating within the Healthcare sector.
| Ticker | ABUS |
| Name | Arbutus Biopharma |
| Currency | USD |
| Sector | Healthcare |
Reputation
Reputation builds as news about this company is analysed.
Price history & forecast
30-day forecast — Linear regression, Holt's exponential smoothing, and drift, plus a news-adjusted consensus (sentiment tilt +0.00). Estimates only, not advice.
Candlestick, volume & news sentiment
Open/high/low/close candles with volume beneath; hover for OHLC, change and volume. Dots mark analysed news by sentiment; shaded bands are when the market was closed. Day and Week show intraday detail; Month+ show daily candles. Step through time with ‹ ›.
Forecast accuracy (backtested)
No scored forecasts yet. Every visit records the day's forecast; once those predicted dates pass, this table fills in with how each method actually did (1 snapshot(s) recorded so far, none matured yet).
Technical analysis
BEARISHComputed from 255 locally-stored price bars.
AI signals
-
HOLD 70% · long_term 2026-06-08 10:01
The stock has been in a downtrend with no significant positive news or catalysts recently, leading to a cautious recommendation. The recent close at 4.25 is below the moving average and shows continued weakness.
qwen2.5:3b
Related news
- No matched headlines yet.